Deutsche Bank
LUCD icon

Deutsche Bank’s Lucid Diagnostics LUCD Stock Holding History

Deutsche Bank’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.4K Hold
80,355
– – ﹤0.01% 3307
2025
Q4 		$87.6K Buy
+80,355
New +$89.8K ﹤0.01% 3333
2025
Q3 		– Sell
-76,301
Closed -$87.7K – 3679
2025
Q2 		$87.7K Buy
+76,301
New +$98.5K ﹤0.01% 3304
2022
Q2 		– Sell
-2,747
Closed -$9K – 4240
2022
Q1 		$9K Sell
2,747
-320
-10% -$1.17K ﹤0.01% 4125
2021
Q4 		$16K Buy
+3,067
New +$24.9K ﹤0.01% 4137

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Deutsche Bank's LUCD Position: Q1 2026 in Review

Deutsche Bank held its Lucid Diagnostics (LUCD) position steady in Q1 2026 at 80,355 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3307.

Deutsche Bank first reported a position in LUCD in Q4 2021 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Deutsche Bank held 80,355 shares of Lucid Diagnostics worth $92.4K as of Q1 2026.
  • Deutsche Bank left its Lucid Diagnostics share count unchanged in Q1 2026.
  • Lucid Diagnostics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3307 holding.
  • Deutsche Bank first reported a position in Lucid Diagnostics in Q4 2021 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.